Streptococcus pneumoniae: Resistance update and treatment options

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Streptococcus pneumoniae is a major worldwide bacterial pathogen responsible for a variety of infections including pneumonia, bacteremia, otitis media, meningitis, sinusitis, and other infections. It is the most common pathogen causing bacterial community-acquired pneumonia (CAP) (1). Pneumococcal pneumonia has always been responsible for significant morbidity and mortality. In the pre-antibiotic era, it carried a 25% to 35% case fatality rate, which increased to 80% if bacteremia was present (2). Following the introduction of penicillin, mortality rates were reduced to below 10% (3). Sixty years later, mortality rates still remain around 12% for all hospitalized patients (1) and up to 25% for those with bacteremia (1,4). The continued significant mortality of pneumococcal disease despite the advances in antimicrobial therapy and intensive care management over the past half-century underscores the innate pathogenicity of this organism.

Original languageEnglish (US)
Title of host publicationAntimicrobial Resistance
Subtitle of host publicationProblem Pathogens and Clinical Countermeasures
PublisherCRC Press
Pages111-124
Number of pages14
ISBN (Electronic)9781420017236
ISBN (Print)9780824729417
StatePublished - Jan 1 2007

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Streptococcus pneumoniae: Resistance update and treatment options'. Together they form a unique fingerprint.

Cite this